INVITRO ACTIVITY OF RO-15-8074, A NEW ORAL CEPHALOSPORIN

被引:21
作者
PEETERS, M
PIOT, P
机构
关键词
D O I
10.1093/jac/16.4.469
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:469 / 473
页数:5
相关论文
共 5 条
[1]   INVITRO ACTIVITY OF U-63196E, A NEW CEPHALOSPORIN, AGAINST CLINICAL BACTERIAL ISOLATES [J].
ELIOPOULOS, GM ;
GARDELLA, A ;
DEGIROLAMI, P ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :401-404
[2]   INVITRO EVALUATION OF HR810, A NEW WIDE-SPECTRUM AMINOTHIAZOLYL ALPHA-METHOXYIMINO CEPHALOSPORIN [J].
JONES, RN ;
THORNSBERRY, C ;
BARRY, AL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (06) :710-718
[3]   INVITRO ANTI-BACTERIAL ACTIVITY AND BETA-LACTAMASE STABILITY OF E-0702, A NEW CEPHALOSPORIN [J].
NEU, HC ;
LABTHAVIKUL, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :313-320
[4]   INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF U-63196E, A NOVEL CEPHALOSPORIN [J].
NEU, HC ;
LABTHAVIKUL, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :375-382
[5]   INVITRO ANTI-BACTERIAL ACTIVITY AND SUSCEPTIBILITY OF THE CEPHALOSPORIN RO 13-9904 TO BETA-LACTAMASES [J].
SHANNON, K ;
KING, A ;
WARREN, C ;
PHILLIPS, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (02) :292-298